	Денежные средства и эквиваленты		Дата
Abbott	USD 8.52B	1.01B	2025-12
Acadia Pharmaceuticals	USD 819.69M	27.33M	2025-12
Agios Pharmaceuticals	USD 89.13M	3.58M	2025-12
Akebia Therapeutics	USD 184.84M	18.4M	2025-12
Alnylam Pharmaceuticals	USD 1.66B	167M	2025-12
AstraZeneca	USD 8.14B	1.08B	2025-09
BioMarin Pharmaceutical	USD 1.31B	61.57M	2025-12
Coherus Biosciences	USD 103.35M	113.54M	2025-09
Eli Lilly	USD 7.27B	2.52B	2025-12
Esperion Therapeutics	USD 92.45M	6.39M	2025-09
Halozyme Therapeutics	USD 133.82M	285.84M	2025-12
Illumina	USD 1.42B	368M	2025-12
Insmed	USD 510.44M	175.68M	2025-12
Ironwood Pharmaceuticals	USD 140.41M	47.56M	2025-09
J&J	USD 19.71B	1.48B	2025-12
Lexicon Pharmaceuticals	USD 21.36M	41.52M	2025-06
MacroGenics	USD 80.13M	50.56M	2025-09
MannKind	USD 74.88M	52.51M	2025-12
Merck	USD 18.17B	10.16B	2025-09
Moderna	USD 2.6B	1.46B	2025-12
Novartis	USD 9.56B	2.9B	2025-09
PTC Therapeutics	USD 984.65M	312.03M	2025-12
Puma Biotechnology	USD 53.52M	1.14M	2025-09
Sarepta Therapeutics	USD 801.28M	188.2M	2025-12
Thermo Fisher Scientific	USD 9.85B	7.87B	2025-12
Ultragenyx Pharmaceutical	USD 202.51M	36.4M	2025-09
United Therapeutics	USD 1.56B	217M	2025-12
Vanda Pharmaceuticals	USD 84.85M	14.83M	2025-12

Lexicon Pharmaceuticals Денежные Средства И Эквиваленты - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2026.